A Study About the Use of Omalizumab in the Treatment of Food Allergy and Anaphylaxis

计划入组 62 人 · 首次发布于 2025 年 6 月 18 日

PK/PD Study of IN-001 Sublingual Spray in Healthy Adults

计划入组 32 人 · 首次发布于 2025 年 10 月 7 日

Potential Allergens in Wine: Double-blind Placebo-controlled Trial

计划入组 48 人 · 首次发布于 2005 年 9 月 14 日

food-ASIT+

DPX-based vaccines (food allergies/ peanut allergy)

DPX-Based Vaccines (food allergies)

Allergy Laboratories, Inc.

United States

Halton Pediatric Allergy

Canada

HAL Allergy BV

Netherlands

ARS Pharma's Neffy Aims to Expand Pediatric Access for Type 1 Allergic Reactions

Omalizumab (Xolair) Receives FDA Approval for Food Allergies in Young Children

Omalizumab Approval and Media Impact Highlight Top Food Allergy Stories of 2024